Related references
Note: Only part of the references are listed.Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype:: Lessons from recent developments in the IARC TP53 database
Audrey Petitjean et al.
HUMAN MUTATION (2007)
Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?
Y. Li et al.
ONCOGENE (2007)
PRIMA-1MET induces nucleolar accumulation of mutant p53 and PML nuclear body-associated proteins
N. Rokaeus et al.
ONCOGENE (2007)
PRIMA-1 induces apoptosis by inhibiting JNK signaling but promoting the activation of Bax
Tao Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB
V. Benoit et al.
ONCOGENE (2006)
New aspects of diagnosis and therapy of hepatocellular carcinoma
J Bruix et al.
ONCOGENE (2006)
Partial volume tolerance of the liver to radiation
LA Dawson et al.
SEMINARS IN RADIATION ONCOLOGY (2005)
In vivo mitochondrial p53 transloclation triggers a rapid first wave of cell death in response to DNA damage that can precede p53 target gene activation
S Erster et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
MC Kew
LIVER INTERNATIONAL (2003)
Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription
JE Chipuk et al.
CANCER CELL (2003)
Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database
VJN Bykov et al.
CARCINOGENESIS (2002)
Live or let die: The cell's response to p53
KH Vousden et al.
NATURE REVIEWS CANCER (2002)
The IARC TP53 database: New Online mutation analysis and recommendations to users
M Olivier et al.
HUMAN MUTATION (2002)
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
VJN Bykov et al.
NATURE MEDICINE (2002)
The effects of wild-type p53 tumor suppressor activity and mutant p53 gain-of-function on cell growth
C Cadwell et al.
GENE (2001)
Nonsurgical treatment of hepatocellular carcinoma
JM Llovet et al.
LIVER TRANSPLANTATION (2000)
Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy
AN Bullock et al.
ONCOGENE (2000)
Share Paper
